RIPA Lysis Buffer
BTL - RIPA Lysis Buffer
Datasheet is currently unavailable. Try again or CONTACT US
Datasheet

RIPA Lysis Buffer

MB-030-0050 MB-030-0250
50 mL 5 x 50 mL
Other, WB
Have a Question? Ask a Specialist
$78.00 /Per Item
$205.00 /Per Item
50 mL $78.00
5 x 50 mL $205.00
Availability: Ships next business day Availability: Ships next business day
Shipping info:

$50.00 to US & Canada for most products. Final costs are calculated at checkout.

Description

Background

RIPA (Radio-Immunoprecipitation Assay) Lysis Buffer enables rapid, efficient cell lysis and solubilization of proteins from both adherent and suspension cultured mammalian cells. It has long been a widely used lysis and wash buffer for small-scale affinity pull-down applications, such as immunoprecipitation, since most antibodies and protein antigens are not adversely affected by the components of this buffer. In addition, RIPA Lysis Buffer minimizes non-specific protein-binding interactions to keep background low, while allowing most specific interactions to occur, enabling studies of relevant protein-protein interactions.  The following RIPA Lysis Buffer components have the following effects: Tris-HCl is a buffering agent prevents protein denaturation, NaCl is a salt that prevents non-specific protein aggregation, NP-40 is a non-ionic detergent to extract proteins; Na-deoxycholate and SDS are ionic detergents to extract proteins; and sodium azide is a bacteriostatic agent added to retard bacterial growth.  RIPA Lysis Buffer is supplied as a ready-to-use solution that requires no preparation. We suggest that the user add protease and phosphatase inhibitors not included with this product prior to use.

Application Note

RIPA Lysis Buffer is ready-to-use as a working 1X solution and requires no further dilution. RIPA Lysis Buffer is intended for the extraction of cellular proteins for the efficient lysis of cells and solubilization of protein, while minimizing protein degradation and maintaining protein immunoreactivity and biological activity. We recommend using 1.0 mL of RIPA Lysis Buffer to lyse 0.5 to 5 x 10E7 adherent mammalian cells. This buffer contains ionic detergents and may not be suitable for kinase enzymes, if these enzymes are easily denatured. Do not add phosphatase inhibitors when preparing lysates for phosphatase assays. 1X RIPA lysis buffer consists of 50 mM Tris HCl, 150 mM NaCl, 1.0% (v/v) NP-40, 0.5% (w/v) Sodium Deoxycholate, 1.0 mM EDTA, 0.1% (w/v) SDS and 0.01% (w/v) sodium azide at a pH of 7.4.  This buffer was meticulously prepared using ultra pure reagents dissolved in highly polished pharmaceutical grade deionized water. Protease and phosphatase inhibitors are recommended but not included in product composition. Recommended final concentrations of protease inhibitors: 1.0 mM Phenylmethylsulfonyl fluoride (PMSF), 10 µM Leupeptin, 0.1 µM Aprotinin, 1.0 µM Pepstatin. Recommended final concentrations of phosphatase inhibitors: 1.0 mM Na3VO4, 1.0 mM NaF.

Purity/Specificity

1X RIPA Lysis Buffer was aseptically filtered through a Millipore 0.22 micron filter into clean, pre-sterilized containers. The product was tested on trypticase soy agar for 24 hours, 48 hours and 72 hours and was found to be negative for bacteria.

Storage Condition

Store container at room temperature (18° to 26° C) prior to opening. Protect from light (store in the dark).

1X RIPA Lysis Buffer - MB-030-0050
1X RIPA Lysis Buffer, 1X RIPA (Radio-Immunoprecipitation Assay) Lysis Buffer, RIPA Buffer
Other, WB
Liquid (sterile filtered)
Ambient
Expiration date is six (6) months from date of opening.
1X
See application note.
0.01% (w/v) Sodium Azide
None
Chun H et al. Inhibition of monoamine oxidase B prevents reactive astrogliosis and scar formation in stab wound injury model. (2022)
Applications
WB, IB, PCA
Kyeong M et al. Endogenous BiP reporter system for simultaneous identification of ER stress and antibody production in Chinese hamster ovary cells. (2022)
Applications
WB, IB, PCA
Kieran NW et al. MicroRNA-210 regulates the metabolic and inflammatory status of primary human astrocytes. (2022)
Applications
WB, IB, PCA
Kim HM et al. Natural Thiols, but Not Thioethers, Attenuate Patulin-Induced Endoplasmic Reticulum Stress in HepG2 Cells. (2021)
Applications
WB, IB, PCA
Nam MH et al. KDS2010, a newly developed reversible MAO-B inhibitor, as an effective therapeutic candidate for Parkinson's disease. (2021)
Applications
WB, IB, PCA
Jung et al. Successful Correction of ALD Patient-derived iPSCs Using CRISPR/Cas9. (2020)
Applications
WB, IB, PCA
Ahn N et al. Effects of Aerobic and Resistance Exercise on Myokines in High Fat Diet-Induced Middle-Aged Obese Rats. (2020)
Applications
WB, IB, PCA
Aleo MD et al. Liver safety evaluation of endothelin receptor antagonists using HepatoPac®: A single model impact assessment on hepatocellular health, function and bile acid disposition. (2019)
Applications
WB, IB, PCA
Javanbakht H et al. Liver-targeted anti-HBV single-stranded oligonucleotides with locked nucleic acid potently reduce HBV gene expression in vivo. (2018)
Applications
WB, IB, PCA
Goode KM et al. Targeting the Hsp90 C-terminal domain to induce allosteric inhibition and selective client downregulation. (2017)
Applications
WB, IB, PCA
Uemura K et al. Early short-term vagal nerve stimulation attenuates cardiac remodeling after reperfused myocardial infarction. (2010)
Applications
Other

Invalid lot number

If you need help finding your CofA, contact us

This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.